Clinical Trial Detail

NCT ID NCT04243785
Title A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors BioTheryX, Inc.
Indications

acute myeloid leukemia

myelodysplastic syndrome

Therapies

BTX-A51

Age Groups: adult senior

No variant requirements are available.